文献速递神经核医学

帕金森病与路易体痴呆的纹状体外多巴胺能与5-羟色胺能通路:123I-FP-CIT SPECT研究

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-05-16

该研究纳入56例无痴呆帕金森病患者、41例路易体痴呆患者和54例对照,采用123I-FP-CIT SPECT评估纹状体外多巴胺能与5-羟色胺能通路。结果显示两组患者均在岛叶、扣带回和丘脑等纹状体外区域出现SBR降低,其中丘脑SBR降低仅见于路易体痴呆且与边缘系统5-羟色胺能投射相关。

要点

  • 帕金森病与路易体痴呆患者均存在岛叶等多巴胺能缺陷。
  • 丘脑5-羟色胺能通路受损与路易体痴呆特异性相关。
  • 纹状体外123I-FP-CIT SPECT的临床价值尚需纵向研究验证。

核心结论

  • 帕金森病和路易体痴呆患者均表现出纹状体外多巴胺能缺陷,而丘脑5-羟色胺能通路受损为路易体痴呆所特有。

研究设计与样本

  • 研究纳入56例无痴呆帕金森病患者、41例路易体痴呆患者和54例对照,每例均接受标准化神经科检查和123I-FP-CIT SPECT。

主要发现

  • 帕金森病和路易体痴呆患者在岛叶、扣带回和丘脑等纹状体外区域的123I-FP-CIT SPECT SBR均降低。
  • 路易体痴呆患者丘脑123I-FP-CIT SBR显著低于对照组和帕金森病患者。
  • 仅在路易体痴呆患者中,丘脑和扣带回123I-FP-CIT SBR缺陷分别与边缘系统5-羟色胺能及广泛皮层单胺能投射相关,而在帕金森病和对照组中仅表现为局部相关。

临床怎么用

  • 123I-FP-CIT SPECT可用于评估帕金森病和路易体痴呆患者的纹状体外多巴胺能与5-羟色胺能通路改变。
  • 丘脑5-羟色胺能通路显像缺陷可能有助于路易体痴呆与帕金森病的鉴别。

局限性

  • 原文指出需纵向研究以确定纹状体外123I-FP-CIT SPECT评估的临床价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the study was to evaluate extrastriatal dopaminergic and serotonergic pathways in patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB) using 123I-FP-CIT SPECT imaging. METHODS: The study groups comprised 56 PD patients without dementia, 41 DLB patients and 54 controls. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. Binding in nigrostriatal and extrastriatal regions of interest was calculated in each patient from spatially normalized images. The occipital-adjusted specific to nondisplaceable binding ratio (SBR) in the different regions was compared among the PD patients, DLB patients and controls adjusting for the effects of age, sex, disease duration and serotonergic/dopaminergic treatment. Covariance analysis was used to determine the correlates of local and long-distance regions with extrastriatal 123I-FP-CIT deficits. RESULTS: Both PD and DLB patients showed lower 123I-FP-CIT SPECT SBR in several regions beyond the nigrostriatal system, especially the insula, cingulate and thalamus. DLB patients showed significantly lower 123I-FP-CIT SBR in the thalamus than controls and PD patients. Thalamic and cingulate 123I-FP-CIT SBR deficits were correlated, respectively, with limbic serotonergic and widespread cortical monoaminergic projections only in DLB patients but exhibited only local correlations in PD patients and controls. CONCLUSION: PD and DLB patients both showed insular dopamine deficits, whereas impairment of thalamic serotonergic pathways was specifically associated with DLB. Longitudinal studies are necessary to determine the clinical value of the assessment of extrastriatal 123I-FP-CIT SPECT.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Pilotto A, Schiano di Cola F, Premi E, et al. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2019. PMID: 31098748. doi:10.1007/s00259-019-04324-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。